IF: 0.957
Cite Score:
1.46
THOMSON REUTERS - SCOPUS

In Silico Analysis of the cadF Gene and Development of a Duplex Polymerase Chain Reaction for Species-Specific Identification of Campylobacter jejuni and Campylobacter coli

AUTHORS

Saeed Shams 1 , Bita Bakhshi 1 , * , Tahereh Tohidi Moghadam 2

AUTHORS INFORMATION

1 Department of Medical Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran

2 Department of Nanobiotechnology, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, IR Iran

ARTICLE INFORMATION

Jundishapur Journal of Microbiology: 9 (2); e29645
Published Online: February 9, 2016
Article Type: Research Article
Received: May 4, 2015
Revised: September 28, 2015
Accepted: November 3, 2015
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background: Campylobacteriosis is a zoonotic infectious disease caused by Campylobacter jejuni and C. coli. The cadF gene is considered as a genus-specific gene while other genes are mainly used for discrimination at the species level.

Objectives: This study aimed to analyze the cadF gene and to develop a duplex PCR assay for simultaneous detection of C. coli and C. jejuni, the two commonly encountered species.

Materials and Methods: In silico analysis of the cadF gene was carried out by several software and available online tools. A duplex PCR optimized with specific primers was used for detection and differentiation of both species. To evaluate specificity and sensitivity of the test, a panel of different Campylobacter spp. together with several intestinal bacterial pathogens was tested. The limit of detection (LOD) of method was determined using serial dilutions of standard genomes.

Results: The analysis of the full size cadF gene indicated variations in this gene, which can be used to differentiate C. jejuni and C. coli. The duplex PCR designed in this study showed that it could simultaneously detect and differentiate both C. jejuni and C. coli with product sizes of 737 bp and 461 bp, respectively. This assay, with 100% specificity and sensitivity, had a limit of detection (LOD) of about 14 and 0.7 µg/mL for C. jejuni and C. coli, respectively.

Conclusions: In silico analysis of the cadF full-gene showed variations between the two species that can be used as a molecular target for differentiating C. jejuni and C. coli in a single-step duplex-PCR assay with high specificity and sensitivity.

Keywords

In Silico Duplex PCR cadF Campylobacter jejuni C. coli

Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background

Campylobacter enteritis is one of the most frequent food-borne infections worldwide (1). Thermophilic C. jejuni and C. coli have been recognized as the most common causes of bacterial diarrhea in humans, especially among children less than five years of age and young adults (2). Although, poultry and poultry products are important sources of Campylobacteriosis, yet the organism can be transmitted to humans via contact with other warm-blooded animals such as cattle, pigs, sheep, ostriches, shellfish, and pets (3, 4).

The symptoms of campylobacteriosis can vary from mild to severe complications, including abdominal pain, fever, myalgia and watery or bloody diarrhea. Although, in most cases the illness is self-limited and rarely fatal yet post-infectious acute immune-mediated neurologic complications such as Guillain-Barre syndrome and Miller Fisher syndrome can occur, which are the consequence of molecular mimicry between lipooligosaccharides (LOS) of bacterial cell wall and gangliosides in peripheral nerves of humans (5, 6). These complications can be prevented or lowered with rapid and accurate detection of etiological agents of the disease. Diagnosis of campylobacteriosis is performed through microbiological, molecular and serological tests. Culture is the gold standard of diagnosis of C. coli and C. jejuni; however, the culture conditions for detection of these fastidious bacteria are complicated and time consuming, which in some cases make the recovery of bacteria unsuccessful. Moreover, the emergence of viable but non-culturable (VBNC) phenotypes should not be ignored.

Differentiation of the two species is only performed through hippurate hydrolysis biochemical test or molecular-based detections (7-10). In molecular methods different genetic targets have been used for the detection Campylobacter species (e.g. asp, hipO, ceuE,cadF, 16SrRNA, 23S rRNA and cdt, fur, glyA, cdtABC, ceuB–E and fliY) (9). Among them, the cadF gene encodes a fibronectin-binding protein that promotes bacteria-host cell interaction and has been described as a conserve and genus-specific gene. In most studies a fragment from this gene with a length of 400 bp is used for identification of Campylobacter spp. at the genus level (1, 11-15). There is no documented bioinformatics study on the cadF gene full-sequence analysis in C. jejuni and C. coli.

2. Objectives

The aim of this study was to analyze the cadF gene and to develop and evaluate a single-step duplex polymerase chain reaction (PCR) assay for simultaneous detection of C. coli and C. jejuni, the two commonly encountered species in human Campylobacteriosis.

3. Materials and Methods
3.1. Alignment of cadF Sequences From GenBank

The cadF sequences from the complete genome of C. jejuni and C. coli were acquired from NCBI GenBank (http://www.ncbi.nlm.nih.gov/) (Table 1). Multiple alignments were performed using the CLC sequence viewer 7.6 software (CLC bio, Aarhus, Denmark).

Table 1. CampylobactercadF Sequences Used in This Study
DefinitionAccession No.
Campylobacter jejuni subsp. jejuni strain MTVDSCj20, complete genome CP008787.1
Campylobacter jejuni subsp. jejuni 00-2538, complete genomeCP006707.2
Campylobacter jejuni subsp. jejuni 00-2544, complete genome CP006709.2
Campylobacter jejuni subsp. jejuni PT14, complete genomeNC_018709.2
Campylobacter jejuni subsp. jejuni NCTC 11168 complete genomeAL111168.1
Campylobacter jejuni RM1221, complete genomeCP000025.1
Campylobacter jejuni subsp. jejuni 81116, complete genomeCP000814.1
Campylobacter coli RM2228 cont193, whole genome shotgun sequenceAAFL01000010.1
Campylobacter coli RM1875, complete genomeCP007183.1
Campylobacter coli 15-537360, complete genomeCP006702.1
Campylobacter coli RM5611, complete genomeCP007179.1
Campylobacter coli CVM N29710, complete genomeCP004066.1
Campylobacter coli RM4661, complete genomeCP007181.1
Campylobacter coli JV20 contig00034, whole genome shotgun sequenceAEER01000022.1
Campylobacter coli JV20 genomic scaffold SCAFFOLD1, whole genome shotgun sequenceGL405235.1
3.2. In Silico Analysis of the cadF Gene

The conserved internal fragment (400 bp) of the cadF gene, reported by Konkel et al. (15) as a specific gene for detection of Campylobacter spp., was used as a reference sequence in this study. This fragment and other selected sequences from the full gene of cadF were subjected to in silico analysis with the online NEB cutter program (http://tools.neb.com/NEBcutter) to compare and select a proper restriction endonuclease for discriminating between C. jejuni and C. coli using analysis of enzymatic digestion pattern.

3.3. Designing a Duplex Polymerase Chain Reaction Assay for Specific Detection of Campylobacter jejuni and C. coli

The entire cadF sequence obtained from GenBank was robustly examined for the presence of intra-species conserved regions, which could differentiate inter-species. Universal forward primer, FU, (position 101 - 120) and reverse primer, R1, (position 478 - 497) were selected for the cadF gene, and were previously described by Konkel et al. (15). Other reverse primers, R2 (position 542 - 561) and R3 (position 818 - 837), were designed in this study using the Genrunner and CLC sequence viewer software (Table 2). Analysis of the designed primers was performed by the Primer-BLAST on NCBI (http://www. ncbi.nlm.nih.gov/). Schematic representation of the PCR amplification of fragments related to C. jejuni and C. coli in duplex PCR is shown in Figure 1. Oligonucleotide primers were synthesized by TAG Copenhagen (Denmark).

Table 2. Primer Sequences for the cadF Gene Used in the Duplex Polymerase Chain Reaction Assaya
PrimerSequence ( 5' to 3' )Size of Product, bpTargetReference
FUTTGAAGGTAATTTAGATATG400Campylobacter spp.(15)
R1CTAATACCTAAAGTTGAAAC400Campylobacter spp(15)
R2TTTATTAACTACTTCTTTTG461C. coliThis study
R3ATATTTTTCAAGTTCATTAG737C. jejuniThis study

aAnnealing temperature is 43°C for all the primers.

Figure 1. Position of Primers for Developing the Duplex Polymerase Chain Reaction Assay
Position of Primers for Developing the Duplex Polymerase Chain Reaction Assay

Black thin lines of 999 and 960 bp are related to the cadF gene of C. coli and C. jejuni, respectively. The discontinuity is related to deletion in C. jejuni. A, produced a 400-bp fragment from both C. jejuni and C. coli (as the positive control of the assay); B, produced a 461-bp fragment from C. coli; C, produced a 737-bp fragment from C. jejuni.

The duplex-PCR was carried out in a 25-μL reaction mixture, containing 10 ng of DNA template extracted by the boiling method, 2.5 μL PCR buffer 10X, 200 μM dNTP, 5 mM MgCl2, 0.1 μM of each primer, 1 unit of Taq DNA polymerase, and sterile deionized water (12, 14). Amplification conditions were 95°C for three minutes (one cycle), then denaturation at 94°C for 30 seconds, annealing at 43°C for 30 seconds and extension at 72°C for 30 seconds for 32 cycles in a thermocycler (Eppendorf, Hamburg, Germany). Finally, an additional extension step (five minutes, 72°C) was carried out.

3.4. Limit of Detection, Sensitivity and Specificity of the Duplex Polymerase Chain Reaction

Limit of detection (LOD) of the amplification assay was evaluated using serial 10-fold dilutions of genomes with initial concentrations of 140 (C. jejuni) and 7 (C. coli) µg/mL. A total of 20 clinical and environmental Campylobacter isolates were examined for further evaluation of the sensitivity. Specificity of the test was evaluated using genomic DNA from standard and isolated clinical strains of other enteric non-Campylobacter bacterial pathogens (Table 3). Sensitivity and specificity were calculated according to the following Equations (16):

Equation 1.
Equation 2.
Table 3. List of Bacteria Used for the Determination of Specificity and Sensitivity of cadF-Targeted Species-Specific Duplex Polymerase Chain Reactiona
Organism NameStrain NameAmplification with Newly Designed Primers
Shigella sonneiATCC 25931negative
Shigella flexneriATCC 12022negative
Shigella boydiiATCC 8700negative
Shigella dysenteriaeATCC 13313negative
Aeromonas hydrophilaATCC 7966negative
Enterobacter aerogenesATCC 13048negative
Vibrio choleraeATCC 39315negative
Enteropathogenic Escherichia coli ATCC 43887negative
Escherichia coli O157:H7ATCC 35150negative
Enteroinvasive Escherichia coliATCC 43893negative
Enteroaggregative Escherichia coliATCC 33780negative
Enterotoxigenic Escherichia coliATCC 35401negative
Salmonella typhimuriumATCC 29946negative
Salmonella typhiATCC 19430negative
Campylobacter jejuniATCC 29428positive
Campylobacter coliATCC 43478positive
Campylobacter coli Isolate 1positive
Campylobacter coli Isolate 2positive
Campylobacter coli Isolate 3positive
Campylobacter coliIsolate 4positive
Campylobacter coli Isolate 5positive
Campylobacter coli Isolate 6positive
Campylobacter coli Isolate 7positive
Campylobacter coli Isolate 8positive
Campylobacter coli Isolate 9positive
Campylobacter jejuniIsolate 1positive
Campylobacter jejuniIsolate 2positive
Campylobacter jejuniIsolate 3positive
Campylobacter jejuniIsolate 4positive
Campylobacter jejuniIsolate 5positive
Campylobacter jejuniIsolate 6positive
Campylobacter jejuniIsolate 7positive
Campylobacter jejuniIsolate 8positive
Campylobacter jejuniIsolate 9positive
Campylobacter jejuniIsolate 10positive
Campylobacter jejuniIsolate 11positive

aSource of isolations is clinical.

4. Results
4.1. In Silico Analysis of the cadF Gene

The length of the cadF sequences extracted from complete genome of C. jejuni and C. coli was 960 (with C + G 31.8% and A + T 68.2%) and 999 bp (with C + G 34% and A + T 66%), respectively. The cadF gene in both species was located after the rpsI gene, which coded for a 30S ribosomal protein. Although there were some nucleotide variations along the sequence of cadF between the two species, yet the main difference was related to the 39-bp deletion in the positions of 533 - 544 and 560 - 586 of C. jejuni (Figure 2). The results of the BLAST analysis of cadF gene showed an average sequence identity of 98.5% and 94% among C. jejuni and C. coli strains, respectively. The identity between the two species was also estimated as 88%, approximately (Table 4).

Figure 2. Analysis and Multiple Alignment of the cadF Complete Gene of Campylobacter jejuni (960 bp) and C. coli (999 bp) by the CLC Software
Analysis and Multiple Alignment of the cadF Complete Gene of Campylobacter jejuni (960 bp) and C. coli (999 bp) by the CLC Software

Dashes in the lower box indicate deleted nucleotides in C. jejuni. The blue box is the conserved 400-bp internal region introduced by Konkel et al.

Table 4. The Distribution of Nucleotides and the Percentage Identity of the cadF Gene
Values
Campylobacter spp.
C. jejunia
C + G305 (31.8)
A + T655 (68.2)
C. colia
C + G340 (34)
A + T660 (66)
Identity between strains, %
C. jejuni and C. jejuni97 - 100
C. coli and C. coli88 - 100
C. jejuni and C. coli85 - 91

aValue are presented as No. (%).

The analysis of the cadF gene 400-bp product sequence (Figure 2), introduced by Konkel et al. via the NEBcutter online web site, indicated that this part of the gene is conserved and there are no commercially proper restriction enzymes to produce fragments with good intervals to differentiate between C. jejuni and C. coli (15) The selected segments of the cadF gene in this study were theoretically appropriate for enzymatic digestions and the produced fragments could be used for species differentiation.

4.2. Design and Evaluation of a Species-Specific Duplex Polymerase Chain Reaction Assay

Duplex PCR showed that it could simultaneously detect both C. jejuni and C. coli with product sizes of 737 bp and 461 bp, respectively (Figure 3). Specificity and sensitivity of the duplex PCR assay was determined to be 100% with exclusive amplification for C. jejuni and C. coli, while this result was negative for other non-Campylobacter enteric bacterial species. The assay showed limit of detection (LOD) of 14 and 0.7 µg/mL (approximately equal to 7 × 109 and 3 × 108 copy number) for C. jejuni and C. coli, respectively.

Figure 3. Agarose Gel Electrophoresis of the Duplex Polymerase Chain Reaction Assay with Specific Primers
Agarose Gel Electrophoresis of the Duplex Polymerase Chain Reaction Assay with Specific Primers

Lanes 1 and 2, 400-bp fragment of the cadF gene of Campylobacter jejuni and Campylobacter coli, respectively as positive controls; lanes 4 - 6, 737 bp fragment of C. jejuni; lanes 9 - 11, 461 bp fragment of C. coli; lanes 3, 7, 8, 12 and 13, negative controls; lane M, 1 kb molecular weight marker.

5. Discussion

Campylobacter jejuni and C. coli are now recognized as important causes of acute bacterial diarrhea in most countries. The isolation and discrimination of C. jejuni and C. coli by biochemical tests at the species level is limited and laborious, thus there is a crucial need to develop a sensitive, validated and rapid DNA-based method for detection of Campylobacter at the species level (10, 17). In some studies, multiple genes have been used for distinguishing C. jejuni and C. coli. Al Amri et al. (2007) developed a multiplex PCR assay using the combination of a genus-specific virulence gene (cadF) together with hippuricase and aspartokinase genes (asp) for species-specific identification of C. jejuni and C. coli, respectively (11). In a study by Cloak and Fratamico (2002), a multiplex PCR was designed for differentiation of C. jejuni and C. coli by means of cadF and ceuE genes. In another work by Adzitey and Corry (2011), lpxA, hipO and glyA genes were used for differentiating C. jejuni and C. coli species. The study of Nayak et al. (2005) was also designed with cadF, ceuE and oxidoreductase subunit genes as fragments of 400-bp conserved region in Campylobacter spp. 894-bp specific for C. coli and 160-bp specific for C. jejuni, respectively (14, 18, 19).

Our duplex PCR method was developed only with the cadF gene and the specificity and sensitivity of novel reverse primers (R2 and R3) in association with a previously described forward primer (FU) was studied. The PCR assay designed in this work showed 100% sensitivity and specificity while no amplification product was seen for the genomic DNA from non-Campylobacter enteric bacteria. One applicable advantage of this newly designed duplex PCR assay is that the amplified products are of different sizes, which can be concurrently visualized on agarose gel without the need to duplicate the reaction or further electrophoresis and sequencing. In a similar study, Klena et al. used divergence and conservation regions of lpxA to develop a robust PCR assay. They differentiated C. coli, C. jejuni, C. lari and C. upsaliensis using multiplex PCR with the lipid A gene lpxA, encoding a UDP-N- acetyl glucosamine acyl transferase. Another work similar to our research was the study of Gonzalez et al. They discriminated C. jejuni and C. coli by using ceuE gene diversity (approximately 13%) between two species (20, 21).

The lowest concentration of genomic DNA for detection of C. jejuni and C. coli was 14 and 0.7 µg/mL (approximately equal to 7 × 109 and 3 × 108 copy number), respectively. These LODs are almost comparable with the study conducted by Wisessombat et al., in which the sensitivity of the multiplex PCR for the detection of Campylobacter spp. was 2 × 105 CFU/PCR (22). Another study indicated that the colony multiplex PCR sensitivity range for C. jejuni and C. coli was 108 to 1013 and 106 to 1013 CFU/mL, respectively (23).

The bioinformatics data analysis of the 400-bp internal section of the cadF introduced by Konkel et al. which has been used by many investigators for genus-specific detection of Campylobacter spp. showed that this fragment is highly conserved among C. jejuni and C. coli strains and is significantly validated for the identification of both species. It seems that there is a concomitant general misjudged belief that the cadF full-gene is genus-specific. Our analysis of total cadF sequence revealed that other than single-nucleotide variations between two bacteria, an approximately 4% deletion has occurred in the cadF sequence of C. jejuni compared with C. coli, which could be useful for our work. The intra-species identity level among C. jejuni and C. coli strains was about 98.5% and 94%, respectively. The identity level was approximately 88% between the two species. These results were similar to the report of Konkel et al. with 87% identity between C. jejuni and C. coli and 98.6% among C. jejuni strains, individually (15).

There are several articles about the PCR-RFLP method for the differentiation of Campylobacter spp. using genes other than cadF (24, 25). Although the restriction pattern of enzymatic digestion of the 400-bp fragment introduced by Konkel et al. is not suitable for separation of the two species, yet the enzymatic digestion of the full-length gene may be useful for differentiation and clinical diagnosis of C. jejuni and C. coli (15) The cadF full-gene has some variations in its sequence and length between species, which can be beneficial for developing a duplex PCR. The designed PCR assay in this study is highly sensitive and specific and provides an accurate, inexpensive, sensitive and specific tool for rapid and simultaneous detection and differentiation of C. coli and C. jejuni in clinical settings.

Footnotes
References
1 Randall L, Lemma F, Rodgers J, Vidal A, Clifton-Hadley F. Development and evaluation of internal amplification controls for use in a real-time duplex PCR assay for detection of Campylobacter coli and Campylobacter jejuni. J Med Microbiol. 2010; 59: 172-8[DOI][ PubMed ]
2 Galanis E. Campylobacter and bacterial gastroenteritis. CMAJ. 2007; 177(6): 570-1[DOI][ PubMed ]
3 Sarkar SR, Hossain MA, Paul SK, Ray NC, Sultana S, Rahman MM, et al. Campylobacteriosis - an overview. Mymensingh Med J. 2014; 23(1): 173-80[ PubMed ]
4 World Health Organization . Campylobacter Fact Sheet N255.
5 Haag LM, Fischer A, Otto B, Grundmann U, Kuhl AA, Gobel UB, et al. Campylobacter jejuni infection of infant mice: acute enterocolitis is followed by asymptomatic intestinal and extra-intestinal immune responses. Eur J Microbiol Immunol (Bp). 2012; 2(1): 2-11[DOI][ PubMed ]
6 Godschalk PC, Kuijf ML, Li J, St Michael F, Ang CW, Jacobs BC, et al. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes. Infect Immun. 2007; 75(3): 1245-54[DOI][ PubMed ]
7 Williams LK, McMeechan A, Baalham T, Ward L, Humphrey TJ, Jorgensen F. Detection of Campylobacter jejuni and Campylobacter coli from broiler chicken-related samples using BAX PCR and conventional International Organization for Standardization culture. J Food Prot. 2008; 71(4): 835-8[ PubMed ]
8 Jackson DN, Davis B, Tirado SM, Duggal M, van Frankenhuyzen JK, Deaville D, et al. Survival mechanisms and culturability of Campylobacter jejuni under stress conditions. Antonie Van Leeuwenhoek. 2009; 96(4): 377-94[DOI][ PubMed ]
9 Persson S, Olsen KE. Multiplex PCR for identification of Campylobacter coli and Campylobacter jejuni from pure cultures and directly on stool samples. J Med Microbiol. 2005; 54: 1043-7[DOI][ PubMed ]
10 Kulkarni SP, Lever S, Logan JM, Lawson AJ, Stanley J, Shafi MS. Detection of campylobacter species: a comparison of culture and polymerase chain reaction based methods. J Clin Pathol. 2002; 55(10): 749-53[ PubMed ]
11 Al Amri A, Senok AC, Ismaeel AY, Al-Mahmeed AE, Botta GA. Multiplex PCR for direct identification of Campylobacter spp. in human and chicken stools. J Med Microbiol. 2007; 56: 1350-5[DOI][ PubMed ]
12 Ghorbanalizadgan M, Bakhshi B, Kazemnejad Lili A, Najar-Peerayeh S, Nikmanesh B. A molecular survey of Campylobacter jejuni and Campylobacter coli virulence and diversity. Iran Biomed J. 2014; 18(3): 158-64[ PubMed ]
13 Patrone V, Campana R, Vallorani L, Dominici S, Federici S, Casadei L, et al. <italic>CadF</italic> expression in Campylobacter jejuni strains incubated under low-temperature water microcosm conditions which induce the viable but non-culturable (VBNC) state. Antonie Van Leeuwenhoek. 2013; 103(5): 979-88[DOI][ PubMed ]
14 Nayak R, Stewart TM, Nawaz MS. PCR identification of Campylobacter coli and Campylobacter jejuni by partial sequencing of virulence genes. Mol Cell Probes. 2005; 19(3): 187-93[DOI][ PubMed ]
15 Konkel ME, Gray SA, Kim BJ, Garvis SG, Yoon J. Identification of the enteropathogens Campylobacter jejuni and Campylobacter coli based on the <italic>cadF</italic> virulence gene and its product. J Clin Microbiol. 1999; 37(3): 510-7[ PubMed ]
16 Roozbehani AD, Bakhshi B, Pourshafie MR, Katouli M. A rapid and reliable species-specific identification of clinical and environmental isolates of Vibrio cholerae using a three-test procedure and recA polymerase chain reaction. Indian J Med Microbiol. 2012; 30(1): 39-43[DOI][ PubMed ]
17 Keramas G, Bang DD, Lund M, Madsen M, Bunkenborg H, Telleman P, et al. Use of culture, PCR analysis, and DNA microarrays for detection of Campylobacter jejuni and Campylobacter coli from chicken feces. J Clin Microbiol. 2004; 42(9): 3985-91[DOI][ PubMed ]
18 Cloak OM, Fratamico PM. A multiplex polymerase chain reaction for the differentiation of Campylobacter jejuni and Campylobacter coli from a swine processing facility and characterization of isolates by pulsed-field gel electrophoresis and antibiotic resistance profiles. J Food Prot. 2002; 65(2): 266-73[ PubMed ]
19 Adzitey F, Corry J. A Comparison between Hippurate Hydrolysis and Multiplex PCR for Differentiating Campylobacter coli and Campylobacter jejuni. Trop Life Sci Res. 2011; 22(1): 91-8[ PubMed ]
20 Klena JD, Parker CT, Knibb K, Ibbitt JC, Devane PM, Horn ST, et al. Differentiation of Campylobacter coli, Campylobacter jejuni, Campylobacter lari, and Campylobacter upsaliensis by a multiplex PCR developed from the nucleotide sequence of the lipid A gene lpxA. J Clin Microbiol. 2004; 42(12): 5549-57[DOI][ PubMed ]
21 Gonzalez I, Grant KA, Richardson PT, Park SF, Collins MD. Specific identification of the enteropathogens Campylobacter jejuni and Campylobacter coli by using a PCR test based on the ceuE gene encoding a putative virulence determinant. J Clin Microbiol. 1997; 35(3): 759-63[ PubMed ]
22 Wisessombat S, Inthagard J, Kittiniyom K, Srimanote P, Wonglumsom W, Voravuthikunchai SP. Multiplex PCR for direct identification of thermophilic campylobacter, C. jejuni, C. coli, C. lari and C. upsaliensis and simultaneous detection of CDTB gene. J Rapid Methods Autom Microbiol. 2009; 17(4): 438-54
23 Wang G, Clark CG, Taylor TM, Pucknell C, Barton C, Price L, et al. Colony multiplex PCR assay for identification and differentiation of Campylobacter jejuni, C. coli, C. lari, C. upsaliensis, and C. fetus subsp. fetus. J Clin Microbiol. 2002; 40(12): 4744-7[ PubMed ]
24 Kashoma IP, Kumar A, Sanad YM, Gebreyes W, Kazwala RR, Garabed R, et al. Phenotypic and genotypic diversity of thermophilic Campylobacter spp. in commercial turkey flocks: a longitudinal study. Foodborne Pathog Dis. 2014; 11(11): 850-60[DOI][ PubMed ]
25 Kamei K, Asakura M, Somroop S, Hatanaka N, Hinenoya A, Nagita A, et al. A PCR-RFLP assay for the detection and differentiation of Campylobacter jejuni, C. coli, C. fetus, C. hyointestinalis, C. lari, C. helveticus and C. upsaliensis. J Med Microbiol. 2014; 63: 659-66[DOI][ PubMed ]
COMMENTS

LEAVE A COMMENT HERE: